Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
- PMID: 17826169
- PMCID: PMC2847360
- DOI: 10.1016/S0140-6736(07)61414-7
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveys
Abstract
Background: Mental disorders are major causes of disability worldwide, including in the low-income and middle-income countries least able to bear such burdens. We describe mental health care in 17 countries participating in the WHO world mental health (WMH) survey initiative and examine unmet needs for treatment.
Methods: Face-to-face household surveys were undertaken with 84,850 community adult respondents in low-income or middle-income (Colombia, Lebanon, Mexico, Nigeria, China, South Africa, Ukraine) and high-income countries (Belgium, France, Germany, Israel, Italy, Japan, Netherlands, New Zealand, Spain, USA). Prevalence and severity of mental disorders over 12 months, and mental health service use, were assessed with the WMH composite international diagnostic interview. Logistic regression analysis was used to study sociodemographic predictors of receiving any 12-month services.
Findings: The number of respondents using any 12-month mental health services (57 [2%; Nigeria] to 1477 [18%; USA]) was generally lower in developing than in developed countries, and the proportion receiving services tended to correspond to countries' percentages of gross domestic product spent on health care. Although seriousness of disorder was related to service use, only five (11%; China) to 46 (61%; Belgium) of patients with severe disorders received any care in the previous year. General medical sectors were the largest sources of mental health services. For respondents initiating treatments, 152 (70%; Germany) to 129 (95%; Italy) received any follow-up care, and one (10%; Nigeria) to 113 (42%; France) received treatments meeting minimum standards for adequacy. Patients who were male, married, less-educated, and at the extremes of age or income were treated less.
Interpretation: Unmet needs for mental health treatment are pervasive and especially concerning in less-developed countries. Alleviation of these unmet needs will require expansion and optimum allocation of treatment resources.
Comment in
-
Most people with mental illness are not treated.Lancet. 2007 Sep 8;370(9590):807-8. doi: 10.1016/S0140-6736(07)61392-0. Lancet. 2007. PMID: 17826153 No abstract available.
-
The WHO World Mental Health Survey: its strengths and weaknesses.Issues Ment Health Nurs. 2008;29(2):99-100. doi: 10.1080/01612840701792217. Issues Ment Health Nurs. 2008. PMID: 18293218 No abstract available.
Similar articles
-
Twelve-month mental health service use in six countries of the Americas: A regional report from the World Mental Health Surveys.Epidemiol Psychiatr Sci. 2019 Aug 27;29:e53. doi: 10.1017/S2045796019000477. Epidemiol Psychiatr Sci. 2019. PMID: 31452485 Free PMC article.
-
Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys.JAMA. 2004 Jun 2;291(21):2581-90. doi: 10.1001/jama.291.21.2581. JAMA. 2004. PMID: 15173149
-
Patterns and predictors of health service use among people with mental disorders in São Paulo metropolitan area, Brazil.Epidemiol Psychiatr Sci. 2017 Feb;26(1):89-101. doi: 10.1017/S2045796016000202. Epub 2016 Apr 12. Epidemiol Psychiatr Sci. 2017. PMID: 27066821 Free PMC article.
-
Twelve-month utilization rates and adequacy of treatment for mental health and substance use disorders in Argentina.Braz J Psychiatry. 2019 May-Jun;41(3):238-244. doi: 10.1590/1516-4446-2018-0036. Epub 2018 Nov 8. Braz J Psychiatry. 2019. PMID: 30427387 Free PMC article.
-
The South Africa Stress and Health Study: rationale and design.Metab Brain Dis. 2004 Jun;19(1-2):135-47. doi: 10.1023/b:mebr.0000027424.86587.74. Metab Brain Dis. 2004. PMID: 15214513 Review.
Cited by
-
Responsible governance for mental health research in low resource countries.PLoS Med. 2011 Nov;8(11):e1001126. doi: 10.1371/journal.pmed.1001126. Epub 2011 Nov 22. PLoS Med. 2011. PMID: 22131909 Free PMC article.
-
A cross-national study on prevalence of mental disorders, service use, and adequacy of treatment among Mexican and Mexican American populations.Am J Public Health. 2013 Sep;103(9):1610-8. doi: 10.2105/AJPH.2012.301169. Epub 2013 Jul 18. Am J Public Health. 2013. PMID: 23865664 Free PMC article.
-
Factors affecting the utilization of mental health services among undergraduate students in a Nigerian University.Heliyon. 2022 Nov 9;8(11):e11476. doi: 10.1016/j.heliyon.2022.e11476. eCollection 2022 Nov. Heliyon. 2022. PMID: 36406704 Free PMC article.
-
HIV Treatment for Alcohol and Non-Injection Drug Users in El Salvador.Qual Health Res. 2015 Dec;25(12):1719-32. doi: 10.1177/1049732314568322. Epub 2015 Jan 16. Qual Health Res. 2015. PMID: 25595149 Free PMC article.
-
Mental health care as delivered by Dutch general practitioners between 2004 and 2008.Scand J Prim Health Care. 2012 Sep;30(3):156-62. doi: 10.3109/02813432.2012.688707. Epub 2012 Jul 15. Scand J Prim Health Care. 2012. PMID: 22794194 Free PMC article.
References
-
- Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global Burden of Disease and Risk Factors. Oxford University Press/World Bank; New York, NY: 2006. - PubMed
-
- Tasman A, Kay J, Lieberman JA, editors. Psychiatry. 2nd Edition John Wiley & Sons; Chichester, U. K.: 2003.
-
- Hu TW. Financing global mental health services and the role of WHO. J Ment Health Policy Econ. 2003;6:135–143. - PubMed
-
- Mechanic D. Establishing mental health priorities. Milbank Q. 1994;72:501–14. - PubMed
-
- Kessler RC, Frank RG, Edlund M, Katz SJ, Lin E, Leaf P. Differences in the use of psychiatric outpatient services between the United States and Ontario. N Engl J Med. 1997;336:551–7. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DA016558/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- R03 TW006481/TW/FIC NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R13-MH066849/MH/NIMH NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- R01-TW006481/TW/FIC NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
- R01-MH059575/MH/NIMH NIH HHS/United States
- R01 MH069864/MH/NIMH NIH HHS/United States
- R01-MH61905/MH/NIMH NIH HHS/United States
- R01MH070884/MH/NIMH NIH HHS/United States
- R01 MH061905/MH/NIMH NIH HHS/United States
- R01-MH069864/MH/NIMH NIH HHS/United States
- R01 MH059575/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States